The company's strong EPS growth and reasonable CEO compensat...
The company's strong EPS growth and reasonable CEO compensation suggest good governance and alignment with shareholder interests. The company's financial performance makes it worth watching for growth investors.
Is Now The Time To Put LanZhou Foci PharmaceuticalLtd (SZSE:002644) On Your Watchlist?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment